EMA draft guideline and concept paper for biosimilars

November 28, 2011 11:49 AM

European Medicines Agency (EMA) has published a draft guideline for r-hFSH which is open for public consultation and also the concept paper for the revision of the guideline on biosimilars.

The “draft guideline on non-clinical and clinical development of similar biological medicinal products containing recombinant human follicle stimulating hormone (r-hFSH)” is published on 24th of November on EMA’s homepage and is open for consultation till the end of May, 2012. This products-specific guideline presents the current view of the CHMP  on the non-clinical and clinical requirements for demonstration of comparability of two r-hFSH containing medicinal products.

Concept paper on the revision of the guideline on similar biological medicinal products” is also published on the same date and open for consultation till the end of February, 2012.

CHMP sees following items as problem statements and wants to update the “overarching” guideline with the contributions of interested parties:

– The principles of biosimilarity may have explained in a clearer way
– Numerous terms are in use for “biosimilar” or “similar biological medicinal product”, and often the term “biosimilar” has been used in an inappropriate way
– The feasibility to follow the generic legal basis for some biological products should be discussed
– Some more specific aspects require re-discussion and potentially a refinement.

You can reach both documents on EMA homepage, Public Consultations link.

Leave a Reply

Twitter ID
(ID only. No links or "@" symbols)


Share an Article?

Writing an article is not only a great way to share your knowledge, but it is also a great way to give back to the community.

We value all our contributors and if you have a website, we will surely give a link back to your site and products.
Wanna contribute?

Suggestions?

Biosimilar News was started for the people who are interested in this rapidly growing business area. So if you have suggestions or feedback on how we can improve, please let us know. If you want to see a specific topic covered, answer to a specific question, or anything else of this sort, just write us. We do our best to keep up!
Make a suggestion now!